PROJECT RECORD
Coolant deployed across a blood-products manufacturer's operations
The manufacturer reports Glacier Coolant deployed throughout Boya Biological's manufacturing operations, supporting the refrigeration its blood-products and biochemical production depends on.
Boya Biological Pharmaceutical Group was founded in 1993 and is described by the manufacturer as an integrated medical industry group spanning blood products, biochemical products and pharmaceutical raw materials, headquartered in Fuzhou, Jiangxi Province. It listed on the Shenzhen Stock Exchange in March 2012 and operates through six subsidiaries.
The manufacturer's news archive states that Glacier Coolant products have been deployed throughout Boya Biological's manufacturing operations, supporting the consistent, reliable refrigeration required for high-quality pharmaceutical production. The biology application page on the manufacturer's original website profiles the same company at greater length but names no product, so the deployment statement rests on the later article.
Blood-product manufacturing runs continuous low-temperature process cooling alongside cold storage, so the loop is expected to hold temperature across long uninterrupted campaigns rather than to recover from frequent starts. The catalogue addresses that duty with the LM-8 family, a modified organic-acid-salt coolant presented as non-combustible with anti-rust performance for carbon steel, stainless steel and copper; the manufacturer's material names the family only.
RELATED PRODUCT FAMILIES
Related family — not confirmed for this project.
The published source for this project does not name the fluid supplied. The families below are described in the same catalogue application; confirm the exact model with our technical team.
SOURCE
Each organisation was already named by the manufacturer in its own published material, which is cited below. This project description is adapted from 2026-06 content on the manufacturer’s website: Glacier Coolant original website — news archive, biobanking and biopharmaceutical storage .
Important: Confirm the current model, operating conditions and documentation before specification.
